The US Food and Drug Administration (FDA) has approved a new treatment for adults with chronic hepatitis B, offering some ...

FDA approves GSK and Ionis’ hepatitis B drug Hibsago early, but a boxed warning and weekly lab monitoring could slow uptake.

Anti-CD36 alloimmunization may contribute to severe platelet transfusion refractoriness despite negative human leukocyte ...

A new review in Supportive Care in Cancer reframes chemotherapy-induced thrombocytopenia as a dual destruction of ...

Aspirin is about as ordinary as medicine gets, which is part of why a new dementia finding is turning heads. The idea that such a familiar pill might help prevent dementia is intriguing. What makes ...

A retrospective cohort study of 297 pediatric COVID-19 patients in Indonesia found that platelet count, mean platelet volume, ...

Approval based on phase III data showing unprecedented functional cure rates compared to standard of care ...

The US FDA recently approved Hibsago (bepirovirsen), a new drug for chronic hepatitis B that could help control viral ...

Nutrition education and encouraging pregnant women to engage in antenatal care are key ways to ensure maternal health and ...

Approval based on Phase 3 data showing unprecedented functional cure rates compared to standard of care – – Six-month ...

A panelist discusses how ITP diagnosis remains one of exclusion requiring thorough testing to rule out other causes of thrombocytopenia, followed by patient education about autoimmune diseases and ...

Pennsylvania’s health department issued a health alert Monday as cases of measles in pregnancy and, in turn, cases of ...